基于共价有机框架的纳米平台,具有可调节的机械性能,用于药物输送和癌症治疗
Liefeng Hu1,2, Yonggang Lv2
1School of Materials Science and Engineering, Wuhan Textile University, Wuhan, 430200 PR China.
Mechanobiology in medicine
|May 21, 2025
概括
共价有机框架 (COF) 提供可调节的机械性能,用于先进的药物输送和癌症治疗. 本综述详细介绍了COF机械调节策略及其生物医学应用,强调了未来的研究方向.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米医学是一种纳米医学.
- 生物医学工程 生物医学工程
背景情况:
- 聚合有机框架 (COF) 是具有可调节的机械性能的晶体多孔材料.
- 这些特性受到结构多样性的影响,对生物医学应用至关重要.
- COF越来越多地用于药物输送和癌症治疗.
研究的目的:
- 总结调节COF机械强度的策略.
- 审查最近使用具有定制机械性能的COF用于药物输送和癌症治疗的进展.
- 确定生物医学中COF应用的挑战和未来方向.
主要方法:
- 关于COF合成和机械性质表征的文献综述.
- 分析表明COF在药物输送系统中的应用的研究.
- 对用于癌症治疗的COF研究的审查,包括机制和疗效.
- 讨论与机械强度相关的COF中的结构性质关系.
主要成果:
- 确定了COF机械强度的关键调节策略,包括结构尺寸,孔径和主机-客户相互作用.
- 突出了利用具有不同机械性质的COF来提高药物输送和癌症治疗疗效的重大进展.
- 展示了COF在纳米医学中的多功能性,因为它们具有可适应的机械特性.
结论:
- 可通过各种策略有效调节COF的机械强度,从而为生物医学应用提供精确的控制.
- 在药物输送和癌症治疗方面,COF显示出显著的潜力,为纳米医学提供了新的途径.
- 需要进行进一步的研究,以解决COF基纳米药物的广泛临床转化所面临的挑战.
相关概念视频
Drug Delivery: Overview
1.3K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.3K
Modified-Release Drug Delivery Systems: Rate-Programmed II
139
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
139
Modified-Release Drug Delivery Systems: Overview
243
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
243
Modified-Release Drug Delivery Systems: Rate-Programmed I
175
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
175
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Site-Targeted Drug Delivery Systems: Polymeric Carriers
167
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
167


